In order to determine the pathway of ceramide generation, PKCδ deficient B16F10 melanoma cells were treated with FB1 (10μM) or imipramine (10μM), the well-known inhibitors of de novo and ASMase pathway respectively following cisplatin treatment. Here, PRKCD is linked to melanoma.